دورية أكاديمية

Biological treatment in Felty's Syndrome with profound neutropenia

التفاصيل البيبلوغرافية
العنوان: Biological treatment in Felty's Syndrome with profound neutropenia
المؤلفون: Krzysztof Proc, Marta Madej, Piotr Wiland, Agata Sebastian
المصدر: Rheumatology, Vol 61, Iss 3, Pp 213-218 (2023)
بيانات النشر: Termedia Publishing House, 2023.
سنة النشر: 2023
المجموعة: LCC:Medicine
مصطلحات موضوعية: splenomegaly, neutropenia, felty's syndrome, biological therapies, Medicine
الوصف: A triad of symptoms characterises Felty's syndrome: seropositive rheumatoid arthritis (RA), splenomegaly and neutropenia. The treatment of Felty's syndrome is based on using classic synthetic and biological disease-modifying drugs (DMARDs). In this article, we present a case of a patient with Felty's syndrome who was treated with biologic treatment. A systematic search of the literature on the electronic medical database was conducted. The drugs from the DMARD group, despite reducing the activity of the disease, may cause significant clinical complications. It is important to know about the diagnosis, differentiation and treatment of neutropenia and the prevention of febrile neutropenia. The article discusses the current therapeutic possibilities using both classical and biologic DMARDs.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0034-6233
2084-9834
Relation: https://reu.termedia.pl/Biological-treatment-in-Felty-s-Syndrome-with-profound-neutropenia,167472,0,2.html; https://doaj.org/toc/0034-6233; https://doaj.org/toc/2084-9834
DOI: 10.5114/reum/167472
URL الوصول: https://doaj.org/article/95947eec1492461ea64d2714e4cde802
رقم الأكسشن: edsdoj.95947eec1492461ea64d2714e4cde802
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00346233
20849834
DOI:10.5114/reum/167472